Schonfeld Strategic Advisors LLC Vanda Pharmaceuticals Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $95,191 - $146,123	22,241 New	22,241 $96,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $471,915 - $587,894	49,991 New	49,991 $494,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $156,900 - $211,400	-10,000 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$15.35 - $21.27 $153,500 - $212,700	10,000 New	10,000 $172,000
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $107,130 - $239,971	-14,284 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $176,835 - $249,541	14,284 New	14,284 $235,000

156

44.7M

167K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.